Skip to content
Catalyst

metforminPapers

Papers about metformin

papers
3,984
41 years, by papers

Newest first

2,801 to 2,850 of 3,984

Every paper here, unless its row says otherwiseIndexed under metformin in PubMed's chemical list; returned by a PubMed search for metformin

  • Effects of proton pump inhibitors on metformin pharmacokinetics and pharmacodynamics.

    Drug metabolism and disposition: the biological fate of chemicals2014PMID 24764147

  • Metformin vs insulin in the management of gestational diabetes: a systematic review and meta-analysis.

    Diabetes research and clinical practice2014PMID 24768511

  • Comparison of metformin and repaglinide monotherapy in the treatment of new onset type 2 diabetes mellitus in China.

    Journal of diabetes research2014PMID 24772445

  • Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.

    Journal of clinical pharmacy and therapeutics2014PMID 24806030

  • Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized, double-blind study.

    Diabetic medicine2014PMID 24824197

  • Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes.

    Diabetes care2014PMID 24824548

  • Safety, efficacy and weight effect of two 11β-HSD1 inhibitors in metformin-treated patients with type 2 diabetes.

    Diabetes, obesity & metabolism2014PMID 24828020

  • The safety of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter 2 (SGLT-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

    Diabetes/metabolism research and reviews2014PMID 24829965

  • Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

    Diabetes research and clinical practice2014PMID 24837144

  • Efficacy and safety comparison of add-on therapy with liraglutide, saxagliptin and vildagliptin, all in combination with current conventional oral hypoglycemic agents therapy in poorly controlled Chinese type 2 diabetes.

    Experimental and clinical endocrinology & diabetes2014PMID 24838155Indexed under metformin in PubMed's chemical list

  • Efficacy and safety of dulaglutide monotherapy versus metformin in type 2 diabetes in a randomized controlled trial (AWARD-3).

    Diabetes care2014PMID 24842985

  • First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis.

    Human reproduction update2014PMID 24861556

  • Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus.

    Clinical and experimental pharmacology & physiology2014PMID 24862430

  • Study to determine the durability of glycaemic control with early treatment with a vildagliptin-metformin combination regimen vs. standard-of-care metformin monotherapy-the VERIFY trial: a randomized double-blind trial.

    Diabetic medicine2014PMID 24863949

  • Efficacy and safety of dulaglutide added onto pioglitazone and metformin versus exenatide in type 2 diabetes in a randomized controlled trial (AWARD-1).

    Diabetes care2014PMID 24879836

  • Effects of fasting blood glucose levels and blood pressure and treatment of diabetes and hypertension on the incidence of cardiovascular disease: a study of 740 patients with incident Type 2 diabetes with up to 30 years' follow-up.

    Diabetic medicine2014PMID 24894815

  • HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin.

    Diabetes care2014PMID 24898304

  • METFORMIN: an efficacy, safety and pharmacokinetic study on the short-term and long-term use in obese children and adolescents - study protocol of a randomized controlled study.

    Trials2014PMID 24899137

  • Effects of rosiglitazone vs metformin on circulating osteoclast and osteogenic precursor cells in postmenopausal women with type 2 diabetes mellitus.

    The Journal of clinical endocrinology and metabolism2014PMID 24905061

  • Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome.

    Journal of endocrinological investigation2014PMID 24906976

  • Effect of exogenously administered glucagon versus spontaneous endogenous counter-regulation on glycaemic recovery from insulin-induced hypoglycaemia in patients with type 2 diabetes treated with a novel glucokinase activator, AZD1656, and metformin.

    Diabetes, obesity & metabolism2014PMID 24909093

  • Durability of glycaemic efficacy over 2 years with dapagliflozin versus glipizide as add-on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metformin.

    Diabetes, obesity & metabolism2014PMID 24919526Indexed under metformin in PubMed's chemical list

  • Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis.

    American journal of epidemiology2014PMID 24920786

  • Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes.

    Diabetes care2014PMID 24929430Indexed under metformin in PubMed's chemical list

  • Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial.

    The lancet. Diabetes & endocrinology2014PMID 24948511Indexed under metformin in PubMed's chemical list

  • Vitamin B12 status in metformin treated patients: systematic review.

    PloS one2014PMID 24959880

  • Effect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysis.

    Journal of diabetes research2014PMID 24963493

  • Pharmacokinetic interaction between rosuvastatin and metformin in healthy Korean male volunteers: a randomized, open-label, 3-period, crossover, multiple-dose study.

    Clinical therapeutics2014PMID 24976448Indexed under metformin in PubMed's chemical list

  • Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.

    Cancer prevention research (Philadelphia, Pa.)2014PMID 24985407

  • Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.

    PloS one2014PMID 24988476Also indexed under metformin as a PubMed major topic

  • Effect of piglitazone and metformin on retinol-binding protein-4 and adiponectin in patients with type 2 diabetes mellitus complicated with non-alcohol fatty acid liver diseases.

    Zhongguo yi xue ke xue yuan xue bao2014PMID 24997826

  • Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial.

    Contemporary clinical trials2014PMID 24999075Indexed under metformin in PubMed's chemical list

  • Comparison of repaglinide and metformin versus metformin alone for type 2 diabetes: a meta-analysis of randomized controlled trials.

    Diabetes research and clinical practice2014PMID 25005849

  • Lipid profiling reveals different therapeutic effects of metformin and glipizide in patients with type 2 diabetes and coronary artery disease.

    Diabetes care2014PMID 25011952

  • Combinational therapy with metformin and sodium-glucose cotransporter inhibitors in management of type 2 diabetes: systematic review and meta-analyses.

    Diabetes research and clinical practice2014PMID 25015317

  • Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial.

    Lancet (London, England)2014PMID 25018121

  • The effect of metformin on mortality following cancer among patients with diabetes.

    Cancer epidemiology, biomarkers & prevention2014PMID 25030683

  • Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol.

    BMJ open2014PMID 25031198Indexed under metformin in PubMed's chemical list

  • Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia.

    Journal of gynecologic oncology2014PMID 25045434

  • Metformin reduces circulating malondialdehyde-modified low-density lipoprotein in type 2 diabetes mellitus.

    Clinical and investigative medicine2014PMID 25090264

  • Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review.

    BMC women's health2014PMID 25096410

  • Pharmacological activation of AMPK ameliorates perivascular adipose/endothelial dysfunction in a manner interdependent on AMPK and SIRT1.

    Pharmacological research2014PMID 25108154Indexed under metformin in PubMed's chemical list

  • Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira).

    Diabetes care2014PMID 25114296Indexed under metformin in PubMed's chemical list

  • Pharmacokinetic evaluations of the co-administrations of vandetanib and metformin, digoxin, midazolam, omeprazole or ranitidine.

    Clinical pharmacokinetics2014PMID 25117183Indexed under metformin in PubMed's chemical list

  • Comparative effects of metformin and pioglitazone on YKL-40 in type 2 diabetes: a randomized clinical trial.

    Journal of endocrinological investigation2014PMID 25138574

  • MARCH2: comparative assessment of therapeutic effects of acarbose and metformin in newly diagnosed type 2 diabetes patients.

    PloS one2014PMID 25148570

  • Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin.

    Diabetes, obesity & metabolism2014PMID 25155146

  • Effect of voglibose on the pharmacokinetics of metformin in healthy Korean subjects.

    International journal of clinical pharmacology and therapeutics2014PMID 25161160

  • Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity?

    Diabetes research and clinical practice2014PMID 25172519

  • HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea.

    Diabetologia2014PMID 25208756

The next 50 papers

← Previous 50